CFDE Data Portal | Search H3Y1

	Label	Description
	H3Y1 Gene (Entity type)	ENSG00000269466 - H3.Y histone 1
	GSE176008 8 V 1 AZACITIDINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE115542 digoxin 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 11 V 6 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE190937 AHCY MAT2A knockout Rael 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE109228 OPA1 inhibition neuron 1-Methyl-4-phenyl-1 2 3 6-tetrahydropyridine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE109228 dopamine neuron 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 0 V 1 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 clofilium 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

H3Y1

ENSG00000269466 - H3.Y histone 1

GSE176008 8 V 1 AZACITIDINE HUMAN DN

A Gene Set from LINCS

GSE115542 digoxin 2 v 0 human up

A Gene Set from LINCS

GSE216043 11 V 6 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE190937 AHCY MAT2A knockout Rael 2 v 3 human up

A Gene Set from LINCS

GSE109228 OPA1 inhibition neuron 1-Methyl-4-phenyl-1 2 3 6-tetrahydropyridine 0 v 1 human up

A Gene Set from LINCS

GSE109228 dopamine neuron 0 v 1 human up

A Gene Set from LINCS

GSE172458 0 V 1 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE216043 cisplatin 11 v 4 human dn

A Gene Set from LINCS

GSE102467 clofilium 1 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.